Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Up 16.0% in April

Enzolytics, Inc. (OTCMKTS:ENZC) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 1,387,200 shares, a growth of 16.0% from the March 31st total of 1,196,000 shares. Based on an average trading volume of 28,327,700 shares, the short-interest ratio is presently 0.0 days.

Enzolytics Stock Down 1.9 %

Shares of ENZC traded down $0.00 during trading hours on Monday, hitting $0.01. The stock had a trading volume of 10,291,195 shares, compared to its average volume of 10,280,873. The company’s fifty day moving average is $0.01 and its two-hundred day moving average is $0.02. Enzolytics has a 52 week low of $0.00 and a 52 week high of $0.13.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.